BEAM - Company ID 0001745999
The table below shows Beam Therapeutics Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $213.27M | $219.82M | $288.29M | $267.96M | $282.13M | $527.91M |
| Short-term investments | $830.61M | $933.10M | $923.36M | $807.01M | $868.21M | $692.04M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.07B |
| $1.18B |
| $1.27B |
| $1.10B |
| $1.18B |
| $1.25B |
| Property, plant & equipment | $94.04M | $97.61M | $101.25M | $108.29M | $108.82M | $109.57M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.27B | $1.39B | $1.48B | $1.31B | $1.39B | $1.47B |
| Accounts payable | $20.14M | $13.10M | $12.29M | $9.54M | $10.56M | $7.70M |
| Total current liabilities | $82.08M | $80.88M | $74.56M | $182.56M | $174.13M | $141.55M |
| Long-term debt | $100.36M | $100.26M | $100.19M | - | - | - |
| Total liabilities | $316.40M | $318.91M | $316.36M | $345.08M | $344.34M | $343.78M |
| Retained earnings | -$1.99B | -$1.86B | -$1.74B | -$1.89B | -$1.78B | -$1.68B |
| Total equity | $952.67M | $1.07B | $1.16B | $966.00M | $1.05B | $1.12B |